Clinical Trials Directory

Trials / Completed

CompletedNCT05451381

Vasopressor Requirements Depends on Sedation Strategy

Vasopressor Requirements During Dexmedetomidine Sedation vs Propofol vs Their Combination (Dexmedetomidine and Propofol) Sedation in Patients After Cardiac Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
356 (actual)
Sponsor
Anesthesia Research Group UA · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Most of the patients after cardiac surgery need sedation in the iCU. Sedation strategy could impact the incidence of vasopressor use.

Detailed description

Sedating a patient is a complex process, especially after heart surgery. Sedation has a negative hemodynamic effect. This leads to a decrease in blood pressure and increases the frequency and dose of vasopressors used. The choice of drug for sedation may have an impact on reducing the frequency of use of vasopressor therapy. The goal of the research is compare three strategies: propofol ( sedative agent), dexmedetomidine ( selective α2-adrenergic receptor (α2-AR) agonist that is associated with sedative effect) and their combination for sedation after cardiac surgery.

Conditions

Interventions

TypeNameDescription
DRUGPropofolsedation after cardiac surgery
DRUGDexmedetomidinesedation after cardiac surgery
DRUGDexmedetomidine and Propofolsedation after cardiac surgery

Timeline

Start date
2017-08-01
Primary completion
2022-05-01
Completion
2022-05-29
First posted
2022-07-11
Last updated
2022-07-12

Locations

1 site across 1 country: Ukraine

Source: ClinicalTrials.gov record NCT05451381. Inclusion in this directory is not an endorsement.